Skip to main content
Image removed.

Why Cordlife

Singapore’s first cord blood bank with a successful transplant track record

 

Cordlife Group's Cord Lining, Cord Tissue, Cord Tissue Mesenchymal Stem Cell Release Track Record

Total Releases:

46

The table below features the cord lining, cord tissue or cord tissue mesenchymal stem cell releases performed by Cordlife Group Limited and its subsidiaries.

As a Group, Cordlife has made 46 cord lining, cord tissue or cord tissue mesenchymal stem cell releases, all of which have been used successfully in cellular therapy

NO RELEASE INDICATION RECIPIENT'S RELATIONSHIP STORAGE TIME (in months) TREATMENT FACILITY
1 2015 Cerebral Palsy Self 7.1 RS Mayapada
2 2016 Cerebral Palsy Sibling 12.3 RS Harapan Kita / RS Mayapada
3 2017 Dementia Grandfather 3.6 RS Medistra
4 2017 Spina Bifida Sibling 10.8 RS PON
5 2018 Cerebral Palsy Sibling 7.7 RS Cipto Mangunkusumo
6 2018 Diabetes Grandfather 16.7 RS Medistra
7 2019 Chronic Kidney Disease Grandfather 26.8 Vinski Regenerative Centre
8 2021 Stroke Grandfather 5.5 Vinski Regenerative Centre
9* 2022 Fatty Liver Disease Father 17.3 Private hospital, Philippines
10* 2022 Chronic Kidney Disease Grandfather 17.3 Private hospital, Philippines
11 2022 Cerebral Palsy Sibling 10.5 Private hospital, Indonesia
12* 2023 Diabetes Mellitus Grandmother 20.0 Private hospital, Philippines
13* 2023 Diabetes Mellitus Uncle 20.0 Private hospital, Philippines
14* 2023 Chronic Kidney Disease Father 2.6 Private hospital, Philippines
15* 2023 Osteoarthritis & Diabetes Mellitus Grandfather 7.5 Private hospital, Phillippines
16 2023 Diabetes Mellitus Grandfather 10.5 Terra Clinic
17* 2023 Chronic Kidney Disease Uncle 9.7 Private hospital, Philippines
18 2023 Autism Spectrum Disorder Sibling 7.7 Celltech Stem Cell Centre
19 2023 Symptoms of Speech Delay and Autism Child 88.0 Celltech Stem Cell Centre
20 2024 Autism Spectrum Disorder Sibling 10.2 Jakarta Clinic
21* 2024 Osteoarthritis & Diabetes Mellitus Grandfather (of the baby) 13.5 Private Hospital, Philippines
22* 2024 Chronic Kidney Disease Father (of the baby) 15.1 Private Hospital, Philippines
23 2024 Symptoms of type II Diabetes Mellitus Father (of the baby) 45.9 Celltech Stem Cell Centre, Jakarta
24 2024 Stroke Father (of the baby) 151.2 Celltech Stem Cell Centre, Jakarta
25 2024 Others Grandparent (of the baby) 61.3 Amnion Clinic, Jakarta
26 2024 Others Grandparent (of the baby) 61.3 Amnion Clinic, Jakarta
27 2025 Others Grandmother 10.1 Amnion Clinic, Jakarta
28 2025 Diabetes Mellitus Grandfather 24.4 SCCR, Semarang
29 2025 Allergy Aunt 24.4 SCCR, Semarang
30 2025 Post Laminoplasty Cervical Aunt 24.4 SCCR, Semarang
31 2025 Kidney Failure Grandfather 64.3 Celltech Stem Cell Centre, Jakarta
32* 2026 Others Grandmother (of the baby) 21.1 Private hospital, Philippines
33 2026 Autoimmune diseases Self 89.3 Celltech Stem Cell Centre, Jakarta
34* 2026 Osteoarthritis & Diabetes Mellitus Grandfather (of the baby) 28.0 Private hospital, Philippines
35* 2026 Diabetes Mellitus Great aunt (of the baby) 9.0 Private hospital, Philippines
36* 2026 Dyslipidaemia & Diabetes Mellitus Father (of the baby) 9.0 Private hospital, Philippines
37 2026 Others Maternal Grandfather 6.7 Asia Stem Cell
38 2026 Others Paternal Grandfather 6.7 Asia Stem Cell
39 2026 Others Maternal Grandmother 6.7 Asia Stem Cell
40 2026 Others Father (of the baby) 6.7 Asia Stem Cell
41* 2026 Others Grandfather (of the baby) 6.0 Private hospital, Philippines
42* 2026 Others Grandmother (of the baby) 12.0 Private clinic, Philippines
43* 2026 Pre-Diabetes Mellitus Grandfather (of the baby) 11.0 Private hospital, Philippines
44* 2026 Pre-Diabetes Mellitus Father (of the baby) 23.0 Private hospital, Philippines
45* 2026 Dyslipidaemia, Hyperuricemia, Pre-Diabetes Mellitus Grandmother (of the baby) 39.0 Private hospital, Philippines
46* 2026 Dyslipidaemia, Hyperuricemia, Pre-Diabetes Mellitus Grandfather (of the baby) 39.0 Private hospital, Philippines

*Ready-to-use mesenchymal stem cells stored with Cordlife.

Footnotes:

  • This list shows the cord lining, cord tissue or cord tissue mesenchymal stem cells released by Cordlife and its subsidiaries to support the treatment of various diseases. This should not be used as a reference for the list of treatable diseases by cord lining, cord tissue or cord tissue mesenchymal stem cells. In addition, banking your baby’s cord lining, cord tissue or cord tissue mesenchymal stem cells does not guarantee that the stem cells will provide a cure or be applicable for every situation. The use is ultimately determined by the treating physician.
  • Some releases may be for the same client but released in different period.
  • Indications categorised under "others" included anti-aging therapy (n=4), clinical frailty (n=1), skin rejuvenation (n=1), and wellness (n=4).

MM 14.1-1-b

DCR No. 2026-786
Implementation Date: 14 Aug 2026